The facility in Kabul, Afghanistan, is developing into a significant participant in the regional supply network for Abacavir Sulphate Active Pharmaceutical Ingredient. This Afghan manufacturing capacity represents a substantial step beyond for the Afghan pharmaceutical sector and offers a distinct opportunity to mitigate need on imports. The creati